STOCK TITAN

AlerisLife Provides a Business Update

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

AlerisLife Inc. (Nasdaq: ALR) has appointed Jeff Leer as President and Chief Executive Officer, transitioning from his interim role. He will continue as Chief Financial Officer until a replacement is found. Additionally, the healthcare consulting firm Alvarez & Marsal concluded its operational review, recommending cost cuts, corporate restructuring, and operational changes aimed at improving accountability and increasing occupancy in senior living communities. Further details on these recommendations will be shared during the Q2 financial results call in early August.

Positive
  • Jeff Leer appointed as President and CEO, enhancing leadership stability.
  • Alvarez & Marsal's operational review aims to reduce costs and improve accountability.
Negative
  • Recommendations from Alvarez & Marsal may not be implemented or deliver expected benefits.

Jeff Leer Appointed President and Chief Executive Officer

Alvarez & Marsal Conclude Operational Review and Make Recommendations to the Board of Directors

NEWTON, Mass.--(BUSINESS WIRE)-- AlerisLife Inc. (Nasdaq: ALR) today announced that Jeff Leer has been appointed President and Chief Executive Officer. Mr. Leer had previously been appointed President and Chief Executive Officer on an interim basis. Mr. Leer will also continue to serve as Chief Financial Officer of ALR until a replacement is appointed.

ALR also announced that the healthcare consulting arm of Alvarez & Marsal (A&M) concluded a comprehensive operational review and made recommendations to the Board of Directors. The recommendations made by A&M include cost reductions, a corporate reorganization that is designed to enhance accountability and certain operational changes to support team members to ensure the delivery of high-quality experiences to residents and customers and increase occupancy at the company’s senior living communities. Further information regarding the recommendations made by A&M and the implementation of those recommendations will be discussed during ALR’s second quarter financial results call in early August.

About AlerisLife (Nasdaq: ALR):

AlerisLife enriches and inspires the lives of its older adult customers across the United States by delivering an exceptional and enhanced resident experience to senior living and active adult residents, while also offering lifestyle services to the younger “choice-based” consumer. The Company is headquartered in Newton, Massachusetts. For more information, visit www.alerislife.com.

WARNING REGARDING FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Also, whenever ALR uses words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “will,” “may” and negatives or derivatives of these or similar expressions, ALR is making forward-looking statements. These forward-looking statements are based upon ALR’s present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Actual results may differ materially from those contained in or implied by ALR’s forward-looking statements as a result of various factors. Forward-looking statements involve known and unknown risks, uncertainties and other factors, some of which are beyond ALR's control. For example:

  • Statements about the intended effects of A&M’s proposals, including reducing costs, enhancing accountability, improving resident and customer experiences and increasing occupancy. A&M’s recommendations may be delayed or not implemented and, if implemented, may not result in the anticipated financial and operational benefits for ALR.

The information contained in ALR’s filings with the Securities and Exchange Commission, or SEC, including under “Risk Factors” in ALR’s periodic reports, or incorporated therein, identifies other important factors that could cause ALR’s actual results to differ materially from those stated in or implied by ALR’s forward-looking statements. ALR’s filings with the SEC are available on the SEC's website at www.sec.gov.

You should not place undue reliance upon forward-looking statements.

Except as required by law, ALR does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.

Michael Kodesch, Director, Investor Relations

(617) 796-8234

Source: AlerisLife

FAQ

What changes were announced for AlerisLife Inc. on Jeff Leer's appointment date?

AlerisLife Inc. announced Jeff Leer was appointed as President and CEO, transitioning from his interim role.

What recommendations did Alvarez & Marsal provide to AlerisLife?

Alvarez & Marsal recommended cost reductions, corporate reorganization, and operational changes to enhance accountability and increase occupancy.

When will AlerisLife discuss the Alvarez & Marsal recommendations?

AlerisLife will discuss the implementation of Alvarez & Marsal's recommendations during its second quarter financial results call in early August.

What is Jeff Leer's role in AlerisLife Inc. after his appointment?

After his appointment, Jeff Leer will continue to serve as Chief Financial Officer until a replacement is appointed.

What are the potential risks associated with AlerisLife's operational changes?

The recommendations from Alvarez & Marsal may not be implemented or could fail to deliver the anticipated benefits for AlerisLife.

ALR

NASDAQ:ALR

ALR Rankings

ALR Latest News

ALR Stock Data

44.18M
18.97M
41.5%
18.8%
0.2%
Medical Care Facilities
Healthcare
Link
United States
Newton